Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Download references

Open Access

Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis

Robert D Inman* and Basil Chiu

Arthritis Research & Therapy 2012, 14:R150  doi:10.1186/ar3886

Include


Format